Kezar Life Sciences (KZR) Misses Q1 EPS by 227c

Kezar Life Sciences (NASDAQ: KZR) reported Q1 EPS of ($2.27).

For earnings history and earnings-related data on Kezar Life Sciences (KZR) click here.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c